Industry Focus - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Industry Focus — Business
Industry Focus

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Latest Episodes:

Energy: What We’re Thankful For Nov 28, 2019

Show notes

In honor of Thanksgiving, we’re sharing what we’re thankful for. Motley Fool Contributor Jason Hall and we share the products, investors, investments, and college football players they’re most thankful for.

Stocks Mentioned: CLNE, DXCM

Check out more of our content here:

Healthcare: 3 Beautiful High Growth Stocks Nov 27, 2019

Show notes

With more than $10 billion in annual sales, the global aesthetics market is much bigger than you probably assume. It’s also growing at a double-digit rate and has no reimbursement headaches to deal with. On today’s episode of Industry Focus: Healthcare, host Shannon Jones and Fool.com contributor Brian Feroldi talk about three pure-play aesthetics companies that are all growing fast: InMode, Cutera, and Sientra. Stocks mentioned: INMD, CUTR, SIEN.

Check out more of our content here:

CG: Should You Invest in Blue Jeans? Nov 26, 2019

Show notes

Jeans have been a staple in American fashion for decades, maintaining their prominence despite constant changes in style and fashion. This year we’ve seen a number of denim-focused companies come to market, with an IPO of Levi’s as well as spinoffs of Kontoor Brands (maker of Wrangler and Lee jeans) from VF Corp and Madewell from J.Crew. Motley Fool contributor Asit Sharma joins the show to break down the economics of the jeans business, challenges, growth opportunities, and more!

Stocks Mentioned: LEVI, KTB, Madewell (ticker not yet assigned)

Check out more of our content here:

Financials: 2 Big Acquisitions in the Financial Industry Nov 25, 2019

Show notes

M&A activity is heating up in the financial sector. We just learned that Schwab (NYSE: SCHW) is officially acquiring TD Ameritrade (NASDAQ: AMTD) in an all-stock deal, which will create a wealth management powerhouse with more than $5 trillion under management. Separately, PayPal (NASDAQ: PYPL) is spending $4 billion to acquire deal-finding platform Honey, which could help enhance the shopping experience for PayPal’s 300 million users. Plus, we dive into StoneCo’s (NASDAQ: STNE) third quarter earnings and talk about some of the stocks our listeners are buying.

Check out more of our content here:

Thanks to Health IQ. See if you qualify for lower rates! healthiq.com/fool

Thanks also to Quip. GETQUIP.COM/fool for your first refill free!

Tech: Disney+ Debuts Nov 22, 2019

Show notes

The House of Mouse’s streaming service is now available and over 10 million users have hopped on. We break down how the offering stacks up to competitors like Netflix and HBO, and talk about how the platform fits into the company’s larger strategy.Stocks: DIS, NFLX

Check out more of our content here:

Energy: The NextEra of Renewable Energy (Part 2) Nov 21, 2019

Show notes

Last week, we broke down NextEra Energy, the largest renewable energy provider in the United States. Now, we’re diving into another part of the NextEra Energy family, NextEra Energy Partners (NEP). Motley Fool Contributor Matt DiLallo returns to the show to discuss the advantages and disadvantages of investing in NEP vs. NextEra Energy and how NEP stacks up relative to other renewable energy yieldcos.

Stocks Mentioned: NEP, NEE, TERP, BEP

Check out more of our content here:

Healthcare: Is Amarin's Fish Oil Pill On Track To Become a Blockbuster? Plus, How Gene Editing Company CRISPR Therapeutics Just Took A Big Step Forward Nov 20, 2019

Show notes

Amarin's shares rocketed higher after a key FDA committee recommended expanding the label of its triglycerides lowering drug, Vascepa, to include data showing it can reduce the risk of heart attack and stroke. Meanwhile, shares in CRISPR Therapeutics and partner Vertex Pharmaceuticals are also soaring following the release of interim, early-stage results for its gene-editing therapy for beta thalassemia and sickle cell disease therapy. Stocks: AMRN, CRSP, VRTX

Check out more of our content here:

CG: This Might Be the Biggest, Bestest, Restaurant You've Never Heard Of Nov 19, 2019

Show notes

On this week’s episode of Industry Focus: Consumer Goods host Jason Moser sits down with analyst Emily Flippen to talk about an under-the-radar restaurant taking customer service to the next level, Nike's latest power move, stocks our listeners are buying and much more!

Check out more of our content here:

Financials: Earnings From Green Dot and Square, and our Mogul Real Estate Service Nov 18, 2019

Show notes

It’s been a couple weeks since Fool.com contributor Matt Frankel, CFP appeared on Industry Focus: Financials, so he and host Jason Moser get caught up on the latest results from Green Dot (NASDAQ: GDOT) and Square (NYSE: SQ). Plus, Frankel discusses The Motley Fool’s real estate site Millionacres and its Mogul investing service, and why investors might want to get serious about adding real estate to their portfolios. Finally, we hear from several listeners about the latest stocks they bought and reveal two companies on our watchlists now.

Check out more of our content here:

Tech: Connected TV Nov 15, 2019

Show notes

We've got earnings updates from the three big connected tv players -- Roku, The Trade Desk, and Telaria. We dig into their results and the overall market for connected tv advertising.

Stocks: TTD, ROKU, TLRA

Check out more of our content here:

Related Podcasts